NURTEC ODT: payments to doctors
Payments that named NURTEC ODT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $37.9M
- Providers
- 134,739
- Transactions
- 1,095,728
- Average per transaction
- $35
The per-transaction average — $35 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 134,739 providers the average total is $281, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $15,035,194 | 39.7% |
| Biohaven Pharmaceuticals, Inc. | $13,403,793 | 35.4% |
| Biohaven Pharmaceutical Holding Company Ltd. | $9,361,219 | 24.7% |
| PBG Puerto RICO LLC | $26,214 | 0.1% |
| Pfizer Chile S.A. | $22,240 | 0.1% |
| Whitehall International Inc | $14,000 | 0.0% |
| Pfizer S.A. | $11,940 | 0.0% |
| Biohaven Pharmaceutical Holding Company LTD. | $9,275 | 0.0% |
| Array Biopharma Inc | $69 | 0.0% |